Non Malignant Pain: Symptom Management

Similar documents
Regional Renal Training

Overview of Essentials of Pain Management. Updated 11/2016

Pain and Chronic Kidney Disease

Neuropathic Pain Treatment Guidelines

BACKGROUND Measuring renal function :

Pain Management Management in Hepatic Hepatic and and Renal Dysfunction

Analgesia in patients with impaired renal function Formulary Guidance

Pain Management in a Geriatric Population. Alan Obringer RPh, CPh, CGP Executive Director Senior Care Pharmacy of Florida

NEUROPATHIC CANCER PAIN STANDARDS AND GUIDELINES

Pain Management Strategies Webinar/Teleconference

NATIONAL INSTITUTE FOR HEALTH AND CLINICAL EXCELLENCE SCOPE

GUIDELINES AND AUDIT IMPLEMENTATION NETWORK

Mitigating Risks While Optimizing the Benefits of Pharmacologic Agents to Manage Pain in the Elderly

Knock Out Opioid Abuse in New Jersey:

Location of initiative York Region Chronic Kidney Disease Program, Mackenzie Richmond Hill Hospital, Richmond Hill, ON

PAIN TERMINOLOGY TABLE

Managing Pain after Transplant Denice Economou, RN,MN,CHPN,AOCN

Medications for the Treatment of Neuropathic Pain

Steven Prakken MD Chief, Medical Pain Service Duke Pain Medicine

Analgesia for Patients with Substance Abuse Disorders. Lisa Jennings CN November 2015

Acute Pain NETP: SEPTEMBER 2013 COHORT

POST OPERATIVE PAIN MANAGEMENT: PAIN AND COMPLICATIONS

The pain of it all. Rod MacLeod MNZM. Hibiscus Hospice, Auckland and University of Auckland

SUMMARY OF ARIZONA OPIOID PRESCRIBING GUIDELINES FOR THE TREATMENT OF CHRONIC NON-TERMINAL PAIN (CNTP)

OPIOIDS FOR PERSISTENT PAIN: INFORMATION FOR PATIENTS

Peripheral neuropathy (PN)

tain PHow o Manage Your This patient guide will help you understand:

CHAMP: Bedside Teaching TREATING PAIN. Stacie Levine MD. What is the approach to treating pain in the aging adult patient?

E-Learning Module N: Pharmacological Review

Palliative Prescribing - Pain

A Letter From Home February 2016

Clinical Guideline. Guidelines for the use of opioid analgesics in the management of acute pain in adults

Subject: Pain Management (Page 1 of 7)

Amber D. Hartman, PharmD Specialty Practice Pharmacist James Cancer Center & Solove Research Institute Ohio State University Medical Center

Pain Assessment & Management. For General Nursing Orientation

Cancer Pain. Suresh K Reddy, MD,FFARCS The University of Texas MD Anderson Cancer Center

Pain and the MGH Promise

Where is your pain located? Please use the diagram below to indicate where most of your pain is located.

Mid Essex Locality Guideline for Management of Adult Acute and Chronic Non-Cancer Pain in Primary care

Pain Management in the Elderly. Martha Watson, MS, APRN, GCNS Christie Bowser, RN-BC, RN

Mr. LBP: Case Presentation

Choose a category. You will be given the answer. You must give the correct question. Click to begin.

Spinal Cord Injury Pain. Michael Massey, DO CentraCare Health St Cloud, MN 11/07/2018

Pain Management in Older Adults. Mary Shelkey, PhD, ARNP

Treating the symptoms of kidney failure

Complicated pain. Dr Stephanie Lippett

Acute pain management in opioid tolerant patients. Muhammad Laklouk

OP01 [Mar96] With regards to pethidine s physical properties: A. It has an octanol coefficient of 10 B. It has a pka of 8.4

Legacy Pain Management Center New Patient Questionnaire

Pain. Fears and Facts. What is pain? Factors that Affect People with Pain. Symptom Management

21 st June BDS BASHD Therapeutics Pain and Analgesia. BASHD Therapeutics Analgesics and Pain Management. Links to other BASHD content

Pharmacogenetics of Codeine. Lily Mulugeta, Pharm.D Office of Clinical Pharmacology Pediatric Group FDA

UCSF Pediatric Hospital Medicine Boot Camp Pain Session 6/21/14. Cynthia Kim and Stephen Wilson

Pain. November 1, 2006 Dr. Jana Pilkey MD, FRCP(C) Internal Medicine, Palliative Medicine

Your Health Survey. Forename: Surname: Renal Unit: Type of treatment: If HD, are you: Date of birth: Home Post Code: Date completed: NHS number:

Elements for a public summary

Managing Pain in the Elderly

Elements for a Public Summary

Prescribing in Renal Failure: Re-audit

sensory nerves, motor nerves, autonomic nerves

Analgesic Prescribing with Renal or Liver Impairment for Palliative Care Patients. Dr Thiru Thirukkumaran

Guidelines for the Management of Chronic Non-Malignant Pain (CNMP) in Primary Care (not including neuropathic pain (NeP).

Neuropathic Pain in Palliative Care

Pain Management for Adult sickle cell disease patients: Information for patients, relatives and carers

Berkshire West Area Prescribing Committee Guidance

Palliative and Hospice Care of the Terminally Ill Introduction

Neuropathic pain (pain due to nerve damage)

Renal Palliative Care Last Days of Life

Sharon A Stephen, PhD, ARNP, ACHPN. September 23, 2014

Disclosure. Relationships with commercial interests:

Pain control in Cancer patients. Dr Ali Shoeibi, Assistant Professor of Neurology

CHRONIC PAIN MANAGEMENT

PALLIATIVE TREATMENT BY DR. KHRONGKAMOL SIHABAN MEDICAL ONCOLOGIST

Understanding pain and mental illness Impact on management principles

Acute Pain Management in the Hospital Setting. Alexandra Phan, PharmD PGY-1 Pharmacy Practice Resident Medical Center Hospital Odessa, TX

3/3/2015 CHRONIC PAIN MARGARET ZOELLERS, MSN, APRN

Chronic Non Malignant Pain Opioid Guideline

nextgen precision Test Report

Oxford Kidney Unit A guide to conservative kidney management. Information for Healthcare Professionals

Pain management in Paediatric Palliative Care. Dr Jane Nakawesi 14 th August 2017

Pain Management Documents

Opioid use in older adults Is it a good idea? Regional Geriatric Rounds April 26, 2013

Palliative Care. Dr. N. Steiner Postgraduate course Geneva Foundation for Medical Education and Research

Symptom Control in Cancer Rehabilitation. Ying Guo, MD Department of Palliative, Rehabilitation and Integrative Medicine UT MD Anderson Cancer Center

Dr. P. Rushatamukayanunt 18/01/2016

GUIDELINES ON THE MANAGEMENT OF PAIN DUE TO CANCER IN ADULTS

Describe Identify Compare Recognize

(ADULT) Refer to policy MC.E.48 for neonatal to pediatric pain assessment and management.

Evaluation and Management of Pain in Children

Supportive Care for the Person with Chronic Kidney Disease. Dr. J. Kappel May 2014

Analgesia. This is widely used in palliative care. It has antipyretic and analgesic effects but no anti-

GUIDELINES ON PAIN MANAGEMENT IN UROLOGY

Dr Alistair Dunn. General Practitioner Northland District Health Board Whangarei

Managing Care at End of Life:

Conservative Management of Uraemia

Analgesic Drugs PHL-358-PHARMACOLOGY AND THERAPEUTICS-I. Mr.D.Raju,M.pharm, Lecturer

Palliative Care for Primary Care Providers QUYNH BUI, MD MPH DECEMBER 2015

Postoperative Pain Management. Nimmaanrat S, MD, FRCAT, MMed (Pain Mgt)

Transcription:

Non Malignant Pain: Symptom Management Renal Care Symposium July 2018 Anica Vasic Pain Management Unit St George Hospital

Definitions Prevalence Assessment Treatment Medications Newer agents: tapentadol, cannabis Dr Peter Langron

Pain Unpleasant sensory and emotional sensation +/- potential tissue damage Acute ~ sudden onset, usually definite cause, usually resolves, eg trauma, surgery, rupture cyst Chronic ~present most days for period 3-6 months or more, last beyond expected time eg after surgery, trauma, may not have definite cause

What causes pain in patients with CKD? Multifactorial: Ischaemic Neuropathic Bone Musculoskeletal pain (60-70%) Primary disease Polycystic renal disease Bone disease Osteodystrophy Osteomalacia

Renal failure Uraemic neuropathy Calciphylaxis Co-morbid conditions Cardiovascular disease Ischaemic or diabetic neuropathy Peripheral vascular disease

Assessment Ask Chronic (persistent) pain has biopsychosocial elements Comprehensive assessment must be made Formulation of an appropriate treatment plan

Assessment Tools VAS/Faces/Number ESAS-Renal Edmonton Symptom Assessment Systemrevised Renal Allows for assessment other factors associated with pain depression itch nausea

Assessment Tools VAS: Visual Analogue Scale

Numerical Rating Scale Faces Scale

Edmonton Symptom Assessment System Revised: Renal (ESAS-r: Renal) Please circle the number that best describes how you feel NOW: No Pain 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Pain No Tiredness 0 1 2 3 4 5 6 7 8 9 10 Worst Possible (Tiredness = lack of energy) Tiredness No Drowsiness 0 1 2 3 4 5 6 7 8 9 10 Worst Possible (Drowsiness = feeling sleepy) Drowsiness No Nausea 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Nausea No Lack of 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Appetite Lack of Appetite No Shortness 0 1 2 3 4 5 6 7 8 9 10 Worst Possible of of Breath Shortness of Breath No Depression 0 1 2 3 4 5 6 7 8 9 10 Worst Possible (Depression = feeling sad) Depression No Anxiety 0 1 2 3 4 5 6 7 8 9 10 Worst Possible (Anxiety = feeling nervous) Anxiety Best Wellbeing 0 1 2 3 4 5 6 7 8 9 10 Worst Possible (Wellbeing = how you feel overall) Wellbeing No Itching 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Itching No Problem 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Sleeping Problem Sleeping No 0 1 2 3 4 5 6 7 8 9 10 Worst Possible Other Problem (for example constipation) Date Time Developed by the Edmonton Zone Palliative Care Program and Northern Alberta Renal Program Completed by (check one): Patient Family caregiver Health care professional caregiver Caregiver-assisted

Pain descriptors Neuropathic: Burning, tingling, stabbing, electric shocks Somatic/nociceptive: Dull, achy, well localised Visceral: Deep, squeezing, cramping, distending, vague, poor localisation

Pain frequency and duration Incident pain eg on dialysis Pain on movement Pain at rest Sleep disturbances

Functionality Mobilisation/ activity Activities Social interaction Family supports Expectations!

DASS-21 Depression Anxiety Stress Scale- 21 questions Lower score better Not definitive but consistent with

PSEQ: Pain self efficacy questionnaire 10 item questionnaire Confidence performing activities with pain Includes home chores, socialising, work Functioning without medications Lower score better

What next? Multidisciplinary approach Optimise Revascularise, improve, modify

General non-pharmacologic Improve activity Pacing, stretches, aquarobics, hydrotherapy Improve strength Strength and weight classes, walking Improve socialisation Support groups, walk and talk groups

Psychological therapies Medications- antidepressants, antipsychotics Sleep hygiene CBT Mindfulness

Case Profile: CT 67 female Post-Renal transplant Generalised pain Arrived clinic in wheelchair/crying Generalised anxiety disorder Prescribed minimal analgesics Prescribed psychology and psychiatry interventions Now walking freely, using walker for confidence in public Cracking jokes! Asked about reducing meds further

Let s talk meds..

Medications

Pharmacokinetics Percentage excreted in urine Active metabolites Dialysed? Haemodialysis Peritoneal dialysis Signs of toxicity

Preferred medications CKD 4+5 WHO Step Recommended Use with caution Do not use 1 paracetamol NSAIDS 2 tramadol 3 HYDROmorphone Fentanyl Methadone Buprenorphone oxycodone Morphine Pethidine Propoxyphene Adjuvants Gabapentin pregabalin TCAs

Paracetamol First line analgesic for CKD patients <5% excreted via kidneys Extensively metabolised in liver No dose modification recommended

NSAIDS Reduced GFR Hypertension/hyperkalaemia/Na water retention BUT

Tramadol 90% tramadol and metabolites renal excretion 30%unchanged/60%metabolites Lower doses used ~ 20% usual dose (100 bd max) Dialyzed (h,?p) S/E: CNS depression/twitches/nausea

Morphine Active metabolites rapidly accumulate= do not use 10% excreted in urine Can be dialyzed S/E sedation/confusion/myoclonus/respiratory depression

Oxycodone <10% excreted in urine Metabolised in liver Active metabolites but small percentage Dialyzed Case reports of toxicity BUT consensus is that it is safe to use if monitored

Methadone 15-16% excreted in urine Excreted in faeces Not dialyzed General considered safe Long variable half life (13-47 hours) Effective in neuropathic pain

Buprenorphine Metabolized by liver, minimal renal excretion Metabolites (bup-3-glucuronide and norbuprenorphine) are inactive and can accumulate Dialyzed Give in standard doses Said to have ceiling effect for respiratory depression Considered safe to give in CKD

HYDROmorphone 6% excreted in urine Metabolised in liver with active H3G conjugate which accumulates Active metabolite dialyzed Useful with careful monitoring S/E as with morphine: myoclonus/ sedation/ resp depression

HYDROmorphone or oxycodone?? HYDROmorphone=5x morphine dose=3.5 oxycodone Ie 10mg HYDROmorphone= 50mg morphine=35 oxycodone Similar metabolite profile Multiple formulations of HYDROmorphone Jurnista slow release, Dilaudid immediate release

Better to learn how to use a few drugs Know their effects Know their side effects Know their dosages

Neuropathic Pain

TCA and duloxetine <2% excreted Not dialyzed No dose modification BUT recommended start at lower doses due to anticholinergic side effects.

Gabapentin and Pregabalin 100% renal excretion Dialyzed Modify dose according to egfr Dose post dialysis S/E neurotoxicity

What s new????